Pfizer, Northrop sell big deals as fear of rate rises cools US market
Pfizer and Northrop Grumman ensured that US high grade bond issuance reached its highest May total since 2009 this week, as both faced down an investor base increasingly wary of rising rates.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts